Clinical outcomes following unrestricted use of the everolimus-eluting stent as compared with paclitaxel- and sirolimus-eluting stents




Background


There is currently a paucity of data regarding clinical outcomes after everolimus-eluting stent (EES) implantation [compared to paclitaxel-eluting stents (PES) and sirolimus-eluting stents (SES)] in unselected patients with the whole spectrum of obstructive coronary artery disease.




Methods


The study cohort comprised 6615 consecutive patients who underwent coronary artery stent implantation with EES (519), PES (2036), and SES (4060) at Washington Hospital Center. Patients who received baremetal stents, the zotarolimus-eluting stent, or two different types of drug-eluting stents were excluded. The clinical end points analyzed were death, death or Q-wave myocardial infarction (MI), target lesion revascularization (TLR), target vessel revascularization (TVR), definite stent thrombosis (ST), and major adverse cardiac events (MACE), defined as the composite of death, Q-wave MI, or TLR at 1 year.




Methods


The study cohort comprised 6615 consecutive patients who underwent coronary artery stent implantation with EES (519), PES (2036), and SES (4060) at Washington Hospital Center. Patients who received baremetal stents, the zotarolimus-eluting stent, or two different types of drug-eluting stents were excluded. The clinical end points analyzed were death, death or Q-wave myocardial infarction (MI), target lesion revascularization (TLR), target vessel revascularization (TVR), definite stent thrombosis (ST), and major adverse cardiac events (MACE), defined as the composite of death, Q-wave MI, or TLR at 1 year.

Only gold members can continue reading. Log In or Register to continue

Related posts:

  1. Coronary stenting with MGuard: extended follow-up of first human trial
  2. Economic modeling of new stent platforms to evaluate cost effectiveness: analysis of the TAXUS Liberté vs. TAXUS Express stents in small vessel coronary stenting
  3. Treatment of STEMI with neither PCI nor thrombolysis
  4. Definite stent thrombosis: a 2-center New Zealand registry

Stay updated, free articles. Join our Telegram channel
Tags:
Nov 16, 2017 | Posted by in CARDIOLOGY | Comments Off on Clinical outcomes following unrestricted use of the everolimus-eluting stent as compared with paclitaxel- and sirolimus-eluting stents

Full access? Get Clinical Tree
Get Clinical Tree app for offline access